Omeros Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All 3O8.F news ›Omeros Corporation $OMER Position Decreased by NFSG Corp
Check Out Our Latest Research Report on Omeros Shares of Omeros stock opened at $16.20 on Monday. The business has a 50-day moving average of $18.41 and a 200 day moving average of $13.89. Omeros Corporation has a 12 month low of $6.24 and…
Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA
Omeros is commercializing YARTEMLEA with its own field force in the U.S. market and plans to license commercialization rights to a third party in the European Union (EU) if EU marketing authorization is granted. Due to increasing demand…
Omeros Shares Slide After CHMP Upholds Negative Opinion On Drug; Analyst Sees Buying Opportunity At $16
Shares of Omeros Corp (OMER) slumped 15% on Friday after a European Medicines Agency committee upheld a negative opinion on its drug for a serious post-transplant condition, though H.C. Wainwright dismissed the selloff as overdone. The…
Omeros Faces Second Rejection Of Narsoplimab In Europe – OMER Stock Falls Below Key Support For First Time In Nearly 3 Months
Omeros Corporation (OMER) was on investors’ radar on Friday after the European Medicines Agency (EMA) issued a negative opinion on the marketing application for its treatment of stem cell transplant-associated complications, marking a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net2
-
tradingview.com2
-
defenseworld.net1
-
greekherald.com.au1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.